Published on
08:08 GMT
BDR Pharmaceuticals to Invest $100 Million to Drive Expansion in the U.S.
BDR Pharmaceuticals is in discussions to acquire manufacturing assets worth $100 million in the United States, aiming to strengthen its presence in the lucrative U.S. market. The company, which is backed by multiples and has revenues of around $200 million …
Source:
Chemical Industry Digest
-
Pending
